Ask Your Colleagues About:

Treatment Strategies
 

dual therapy

Posted: May 12, 2007

QUESTION:

I have a female patient of 10 years old She has been treated for 7 years with AZT and 3TC . She is well now ,Her CD4 was 20.92% (nov/18/1999), 13.32%(jan,2, 2007)and resistance test shows resistance to all NRTIs 1.How can we best balance the risk of TAMs and the need to switch to second-line regimens? Especially if we do not have routine access to viral load testing? 2.In what case should we perform suceptibility test before changing treatment regimen ? 3.Four this specific patient ,what ARVs should we use? one doctor suggests to treat patient with Tenofovir because the major mutation to Tenofovir does not appear yet Best of wishes Tran Anh


  

RESPONSE FROM:   

    I am a bit confused. It sounds like this girl has a good CD4 cell count but, I assume, a high viral load?

    You have a recent resistance test that indicates resistance to all NRTIs. Can you list the exact mutations?

    Based on this info I can give my opinion as to whether she should swithc therapy yet and, if so, what to. It would also be helpful to know what HIV meds you have available to you.

    DW




Terms of Use: Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body PRO, Body Health Resources Corporation or any sponsor of this forum.

Visitors submitting questions remain solely responsible for the content of their messages. Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care.

powered by ExpertViewpoint